Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:    
Net loss from continuing operations, including noncontrolling interest $ (553,878) $ (3,349,899)
Adjustments to reconcile net loss to net cash provided by (used in) operations:    
Depreciation and amortization 310,528 469,371
Non-cash interest income (90,653) (212,819)
Original issue discount on debt 50,000
Gain from forgiveness of debt (200,000) (334,819)
Net loss from legal settlements 755,117 129,153
Change in fair value of investment 823,596
Loss on disposal of equipment 1,650
Income from federal government provider relief funds (285,572) (595,692)
Changes in operating assets and liabilities:    
Accounts receivable 23,549 (343,446)
Inventory 44,489 37,868
Prepaid expenses and other current assets 84,172 (93,486)
Security deposits (10,039) 22,284
Change in right-of-use assets 215,062 247,018
Accounts payable 1,167,261 (6,704)
Accrued expenses 1,126,971 3,686,494
Change in right-of-use operating lease obligations (215,062) (247,018)
Income tax assets and liabilities 240,819 312,849
Net cash provided by (used in) operating activities of continuing operations 3,436,360 (227,196)
Net cash (used in) provided by operating activities of discontinued operations (48,497) 8,848
Net cash provided by (used in) operating activities 3,387,863 (218,348)
Cash flows from investing activities:    
Capital expenditures (350,934) (35,230)
Note receivable / receivable from related party (1,180,401) (869,961)
Net cash used in investing activities of continuing operations (1,531,335) (905,191)
Net cash from investing activities of discontinued operations
Net cash used in investing activities (1,531,335) (905,191)
Cash flows from financing activities:    
Proceeds from issuance of related party loans 580,000 1,050,000
Payments on related party loans (1,407,000) (182,000)
Proceeds from issuance of debentures 500,000
Payments of debentures (400,000) (150,000)
Payments on notes payable (1,079,983) (1,415,610)
Receivables paid under accounts receivable sales agreements (688,235)
Proceeds from federal government provider relief funds 284,339
Proceeds from issuances of Series P Preferred Stock 1,500,000
Cash paid for fractional shares in connection with reverse stock split (9)
Net cash (used in) provided by financing activities of continuing operations (2,306,983) 898,485
Net cash from financing activities of discontinued operations
Net cash (used in) provided by financing activities (2,306,983) 898,485
Net change in cash (450,455) (225,054)
Cash at beginning of period 499,470 724,524
Cash at end of period $ 49,015 $ 499,470